Since the start of the pandemic Eurofins (Paris:ERF) has tested thousands of models of surgical and hygienic masks and provided best-in-class speed and certification for PPEs globally, enabling these critical products to get market as fast as possible. Eurofins has developed global leading testing capabilities and certification services in the North America, Europe and Asia ensuring that PPE manufacturers are able to provide the indispensable support needed in the fight against the coronavirus.
As of today, Eurofins is one of the few GLP certified and ISO/IEC 17025 accredited laboratory networks to fully cover all testing requirements for surgical/medical and hygienic masks by the FDA, EU regulations and many international and country-specific directives and guidelines such as CEN, CE Marking, ISO, ASTM or OECD. Our robust portfolio for masks includes globally accepted, safety and performance testing, virucidal, bacterial filtration, particle filtration, differential pressure, biocompatibility, stability, splash resistance and flammability testing where required.
Eurofins is one of the very few testing service providers having developed 0.1 micron PFE (Particle Filtration Efficiency) capabilities to fulfil US regulatory expectations.
Beyond testing and certification services, Eurofins goes the extra mile with “Maskné” testing or skin tolerance studies, documentary review, safety and efficacy claim substantiation.
Eurofins’ highly skilled technical experts also provide assessment and support to manufacturers, importers, retailers and brand owners in ensuring the functionality and safety of masks, adapting the sampling methodology and testing protocols to the country-specific or certification requirements outlined in the standards of the international markets where the products are intended to be distributed.
For more information about the types of masks and their respective scope of compliance, please visit our website www.eurofins.com/COVID-19-product-testing or contact Eurofins’ local experts.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210114005097/en/
Miguel Ángel QUILES GRANADO
E-mail: CPT_marketing@eurofins.com
Permalink: http://www.businesswire.com/news/home/20210114005097/en
